drugset / Trial / NCT03988530
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Safety, Efficacy and Pharmacokinetics of DPI 386 Nasal Gel for the Prevention and Treatment of Nausea Associated with Motion Sickness in Senior Subjects With Open-Label Follow-Up
Timeline
- Start
- 2019-06-07
- Primary completion
- 2020-11-23
- Completion
- 2020-11-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Scopolamine | Unknown | 0.2 mg | Intranasal |